Patients With HFrEF, HFpEF See Different Functional Capacity Benefits With Dapagliflozin

The DETERMINE-Reduced and DETERMINE-Preserved trials demonstrated varying benefits of dapagliflozin on Kansas City Cardiomyopathy Questionnaire Total Symptom Score and Physical Limitation Scale as well as 6-minute walk distance.

Related Keywords

United States ,American , ,American Heart Association Circulation ,York Heart Association ,Kansas City Cardiomyopathy Questionnaire ,Total Symptom Score ,Limitation Scale ,American Heart Association ,New York Heart Association ,Heart Failure ,Hfref ,Hfpef ,Determine ,Dapagliflozin ,Circulation ,